CorTec's Brain Interchange™ BCI System Enables Stroke Patient to Control Computer with his Mind

CorTec GmbH today announced that the first participant in the University of Washington’s NIH-funded clinical trial of the Brain Interchange™ BCI system has successfully controlled a computer through ...
TMCnet

Axoft Secures $55M Series A to Advance Clinical Trials Globally for its Bio-Inspired, Implantable Brain-Computer Interface

Axoft, a neurotechnology company, today announced it has raised an oversubscribed $55 million Series A led by C.P. Group ...
MassDevice

CorTec BCI allows patient to control computer with thought alone

CorTec today announced a major milestone for the first participant in a trial for its Brain Interchange brain-computer ...

A Brain Implant for Depression Is About to Be Tested in Humans

While many brain-computer interface companies are focused on helping paralyzed people communicate, Motif Neurotech is ...
Pharmabiz

Akso Health initiates world-class, proprietary Brain-Computer Interface R&D programme

Akso Health initiates world-class, proprietary Brain-Computer Interface R&D programme: Qingdao, China Wednesday, April 29, 2026, 14:00 Hrs [IST] Akso Health Group (AHG), formerly ...
TechJuice

We Could Soon Get Wireless Brain Implant for Treating Depression

A wireless brain implant for treatment-resistant depression has received FDA clearance for human trials in the United States.

Neuvotion Announces the Launch of NeuStim™ as Part of its AI-Guided Brain-Body Interface Platform for Recovery After Stroke or Injury

Neuvotion, Inc. is an early-stage medical device company developing AI-driven neuromodulation, brain-computer interface (BCI) ...

AHG Announces Initiation of World-Class, Proprietary Brain-Computer Interface R&D Program - Targeting the Next Frontier of Human Neurotechnology

Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") today announced the commencement of its next-generation, proprietary Brain-Computer Interface (BCI) technology research and development ...

Wearable Devices Receives U.S. Patent Notice of Allowance for Biometric User Authentication in Gesture and Voice-Controlled Interface Device

New continuation patent protects the ability to authenticate users from their unique biological signals, unlocking secure payments, user ...
Interesting Engineering on MSN

FDA clears first US trial of wireless brain implant for treatment-resistant depression

A tiny brain implant, no bigger than a blueberry, is moving from lab concept ...
Hosted on MSN

FDA clears first US trial of wireless brain implant for depression

The FDA has granted Motif Neurotech approval to begin the first U.S. clinical trial of its wireless brain implant for ...
TMCnet

Motif Neurotech Receives FDA Approval to Begin First Clinical Trial of its Therapeutic BCI for Treatment-Resistant Depression

Motif Neurotech, a brain-computer interface (BCI) company developing technologies for mental health, today announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational ...